Dr Pinelopi Manousou is a Consultant Hepatologist at Imperial College Healthcare NHS Trust, and Honorary Senior Lecturer at Imperial College London. She leads the NAFLD service in the Trust, overseeing a clinic that cares for more than 600 patients. Her research interests are focused in translational aspects of NAFLD care, including prediction of cardiovascular risk, quantitation of liver biopsies from NAFLD patients using machine learning, and management of NAFLD cirrhosis.
et al., 2021, NAFLD: time to apply quantitation in liver biopsies as endpoints in clinical trials, Journal of Hepatology, Vol:74, ISSN:0168-8278, Pages:241-242
et al., 2020, In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19, Plos One, Vol:15, ISSN:1932-6203
et al., 2020, Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder, Lancet Gastroenterology & Hepatology, Vol:5, Pages:886-+
et al., 2020, Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study, The Lancet Microbe, Vol:1, ISSN:2666-5247, Pages:e245-e253
et al., 2020, High-throughput, machine learning-based quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with nonalcoholic fatty liver disease, Clinical Gastroenterology and Hepatology, Vol:18, ISSN:1542-3565, Pages:2081-2090.e9